Clinical Trials Browser

INDUSTRY × Colonic Neoplasms × regorafenib × Clear all

NCT05839951 2025-11-12

STAR-T

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT02425683 2020-02-10

Study of Colorectal Cancer Patients (Stage IIIC) With Either Regorafenib or Standard of Care (No Treatment) After Adjuvant FOLFOX

Phase 2 Terminated

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms